There were 145 press releases posted in the last 24 hours and 441,884 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Merus’ Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCC

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image